Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Acrivon Therapeutics, Inc. (ACRV)
TipRanks08:10 ET
Acrivon Therapeutics Analyst Ratings
Benzinga14:01 ET
Buy Rating on Acrivon Therapeutics With Increased Target Price Amid Promising ACR-368 Trial Data
TipRanksApr 26 07:20 ET
Acrivon Therapeutics Analyst Ratings
BenzingaApr 25 07:27 ET
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)
TipRanksApr 25 06:30 ET
Acrivon Therapeutics: A Buy Rating With Promising Clinical and Market Outlook
TipRanksApr 22 10:45 ET
Piper Sandler Remains a Buy on Acrivon Therapeutics, Inc. (ACRV)
TipRanksApr 17 07:15 ET
Buy Rating Affirmed for Acrivon Therapeutics on Promising Drug Pipeline and Solid Financials
TipRanksApr 10 14:55 ET
Acrivon Therapeutics: Strategic Finance and Clinical Promise Merit a Buy Rating
TipRanksApr 9 11:15 ET
Acrivon Therapeutics Analyst Ratings
BenzingaApr 5 10:39 ET
Analysts Are Bullish on These Healthcare Stocks: Acrivon Therapeutics, Inc. (ACRV), Abivax SA Sponsored ADR (ABVX)
TipRanksApr 2 15:40 ET
Acrivon Therapeutics Analyst Ratings
BenzingaApr 1 12:21 ET
Buy Rating on Acrivon Therapeutics: Anticipated Clinical Validation and Strong Financial Position
TipRanksApr 1 00:25 ET
Buy Rating Justified by Acrivon Therapeutics' Clinical Progress and Market Potential
TipRanksMar 28 11:55 ET
Acrivon Therapeutics Analyst Ratings
BenzingaMar 1 11:28 ET
Acrivon Therapeutics: A Buy Rating on Revolutionary Precision Medicine Platform and Promising Clinical Trials
TipRanksJan 12 07:15 ET
Promising Initial Results and Ongoing Research Bolster Buy Rating for Acrivon Therapeutics, Inc.
TipRanksNov 11, 2023 13:35 ET
BMO Capital Maintains Outperform on Acrivon Therapeutics, Lowers Price Target to $24
BenzingaNov 10, 2023 15:01 ET
Acrivon Therapeutics Analyst Ratings
BenzingaNov 10, 2023 15:00 ET
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Acrivon Therapeutics, Inc. (ACRV) and Neurocrine (NBIX)
TipRanksNov 10, 2023 08:20 ET
No Data
No Data